US drug prices have increased through product-hopping, other patent abuse, House committee report says

*Areas of Interest

MLex content is primarily organized into different areas of interest that cover the main elements of regulatory risk.

Please indicate which ones you would like to be included in your Daily Wrap-up alert

ANTITRUST & COMPETITION

Data Privacy & Security

Financial Crime

Financial Services, Technology & Energy

Mergers & Acquisitions

State Aid

Trade

MLex Limited and our LexisNexis Legal & Professional group of companies will use your personal information to administer your account and/or provide the products and services that you have requested from us. We may also contact you in your professional capacity with information about our other products, services and events that we believe may be of interest. You can manage your communication preferences via our Preference Center . You can learn more about how we handle your personal data and your rights by reviewing our Privacy Policy .